EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/15/2026
Back to search
Official data from USPTO
NOVALIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
02/20/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
5
Owner type
99
Owner location
Heidelberg, DE
Examiner
DANG, BAO-NGOC K
Law office
L60
Current location
PETITIONS OFFICE
Mark description
The mark consists of the wording "NOVALIQ" displayed in stylized characters in blue color.
Holders and representatives
Holders
Novaliq GmbH
Representatives
Lily Ackerman Synergy IP Group AG
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicamentsmedicines)namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids.
Class 42
Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparationsdermatologic pharmaceutical preparationssemifluorinated alkanes (SFAs) and of topical medical treatments; testingauthentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations.
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/15/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/15/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/15/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/24/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/24/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/17/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/17/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/17/2025
EX1G
SOU EXTENSION 1 GRANTED
10/17/2025
PC.D
PETITION TO DIRECTOR DISMISSED
10/17/2025
APET
ASSIGNED TO PETITION STAFF
10/16/2025
EXT1
SOU EXTENSION 1 FILED
09/10/2025
EEXT
SOU TEAS EXTENSION RECEIVED
09/10/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/09/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/19/2024
GNRT
NON-FINAL ACTION E-MAILED
09/19/2024
CNRT
NON-FINAL ACTION WRITTEN
09/19/2024
DOCK
ASSIGNED TO EXAMINER
09/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/25/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/23/2024
NWAP
NEW APPLICATION ENTERED
02/20/2024
Continuous trademark protection
Get notified about every new filing that threatens NOVALIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.